Abstract B124: Drugging the undruggable: development of small molecule activators of protein phosphatase 2A for cancer treatment
Jaya Sangodkar(Pediatrics and Genetics), Goutham Narla(Pediatrics and Genetics), Yiannis A. Ioannou(Icahn School of Medicine at Mount Sinai), David B. Kastrinsky(Icahn School of Medicine at Mount Sinai), Mark R. Chance(Case Western Reserve University), David L. Brautigan(Brown University), Michael Ohlmeyer(Princeton Satellite Systems (United States)), Janna Kisselar(Case Western Reserve University), Daniel McQuaid(Icahn School of Medicine at Mount Sinai)
Cited by 0
Related Papers
Functional variants in the <i>LRRK2</i> gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease
|Science Translational Medicine|2018|410
Hepatic Niemann-Pick C1–like 1 regulates biliary cholesterol concentration and is a target of ezetimibe
|Journal of Clinical Investigation|2007|372
Transmembrane Molecular Pump Activity of Niemann-Pick C1 Protein
|Science|2000|324
Topological Analysis of Niemann-Pick C1 Protein Reveals That the Membrane Orientation of the Putative Sterol-sensing Domain Is Identical to Those of 3-Hydroxy-3-methylglutaryl-CoA Reductase and Sterol Regulatory Element Binding Protein Cleavage-activating Protein
|Journal of Biological Chemistry|2000|301